The British Pharmacopoeia (BP) 2024 Edition

The British Pharmacopoeia (BP) 2024

Available from 1 August 2023 | Effective from 1 January 2024 | Superseding the BP 2023

The British Pharmacopoeia (BP) 2024 edition, from the Medicines and Healthcare products Regulatory Agency, is the most comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products.

If a pharmaceutical substance or finished product is marketed in a country where the BP is a legal standard, it must comply with the requirements of the BP throughout its shelf life.

Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products.

It includes approximately 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.

All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.

New for the BP 2024

In addition to all European Pharmacopoeia and BP Veterinary texts being included, the new BP 2024 edition also features:

Monographs and BPCRS:

• 27 new BP monographs, 17 new Ph. Eur. monographs.
• 93 amended BP monographs.
• all monographs from the Ph. Eur. 11th edition and Ph. Eur. supplements 11.1 and 11.2.
• Ph. Eur. supplements 11.3 to 11.5 included as in-year online and download product updates.
• updated references to new BPCRS included in the BP 2024 to ensure that you remain compliant

Supporting content:

Analytical Quality by Design (AQbD) guidance for selected monographs  provides additional method understanding and a greater assurance of the analytical procedures used to uphold product quality throughout the product’s lifecycle.

The Advanced Therapy Medicinal Products (ATMP) Flow Cytometry and Vector Copy Number best practice guidance texts offer a practical and phase appropriate validation tool to help your cell therapy programme succeed.

The BP 2024 complete package

• Six-volume printed edition, including the BP (Veterinary) 2024
• Single-user online licence
• Single-user download for offline use